|
1
|
Mehmood S, Hasan SMF, Razzakova CM, Ziganshina LE, Ganbat A, Sanjjav T, Sunderland B, Dorj G, Dorj G, Satibi S, Rokhman MR, Aditama H, Kartini I, Ambarsari R, Pramesti F, Loh PY, Chua SS, Karuppannan M, Verma RK, Paraidathathu T, Taha NA, Chong WW, Rosli MR, Neoh CF, Karuppannan M, Hassan WNW, Mahmud M, Rahimi A, Wu DBC, Teh RE, Ali AM, Mustapha M, Zainal H, Tangiisuran B, Harun SN, Looi I, Sidek NN, Ibrahim KA, Wei LK, Yee LK, Aziz ZA, Al-Sunaidar KA, Aziz NA, Hassan Y, Hameed MA, Shaari NFB, Karuppannan M, Ismail H, Wong YY, Neoh CF, Ramlan RDN, Raman WANA, Radzaini SS, Ghani NA, Lean QY, Neoh CF, Wong YY, Md Shariff A, Karuppannan M, Gnanasan S, Aziz N A, Zaini MH, Wahab MSA, Lkhagvasuren D, Dorjbal E, Leghari QA, Aslam MS, Malick N, Kashif S, Bawani S, Ahmad NSB, Hatah E, Makmor-Bakry M, Nagaria RA, Hasan SS, Babar ZUD, Faller EM, Madelo J, Tolentino EA, Noordin ZM, Karuppannan M, Fen NC, Ghazali NHI, El-Dahiyat F, Rashrash M, Abuhamdah S, Abu Farha R, Khan A, Khan AH, Sulaiman SAS, Adnan AS, Mushtaq S, Fadzil MM, Akmal MHSM, Wong YY, Neoh CF, Lean QY, Malini C, Wahab NABA, Shamsuddin AF, Dali AF, Patah NA, Ibrahim N, Cheah MH, Gan ET, Azman NJ, Kori N, Periyasamy P, Abdul-Aziz SA, Ismail WI, Hassali MAA, Farooqui M, Roslan MNF, Rahim NA, Dzulkarnain SMH, Chigome AK, Matlala M, Meyer JC, Zaidi NHI, Saman KM, Fahrni ML, Sani FA, Gnanasan S, Karuppannan M, Alhebs DN, Hussin NSM, Gnanasan S, Karupannan M, Gopalan Y, Gankhulug B, Tegshee O, Dorj G, Sanjjav T, Sunderland B, Dorj G, Ganbat A, Dorj G, Sanjjav T, Sunderland B, Dorj G, Ariunaa D, Purevsuren S, Tugsbileg S, Boditsetseg B, Baigalmaa D, Bolor B, Otgonbat B, Mandahnaran P, Alhatlani A, Alshehaitan N, Alherabi A, Farooqui M, Gill MS, Basari AH, Adnan MA, Mat Rahim MA, Fauzi NAM, Hamidi NH, Rahman MAA, Ghani NA, Lean QY, Neoh CF, Wong YY, Nasrudin IZ, Zaki NIM, Ismail MFN, Ghani NA, Lean QY, Neoh CF, Wong YY, Aslam A, Zin CS, Syafinaz N, Ahmad SI, Jamshed S, Yahaya H, Suriana HA, Izyan AW, Amlizan R, Phodha T, Riewpaiboon A, Malathum K, Coyte PC, Othman N, Wong YY, Lean QY, Noor NM, Neoh CF, Lertsinudom S, Niamtaworn P, Tanpichart S, Alkhalidi D, Jamshed SQ, Elkalmi RM, Baig MR, Aslam A, Hassali MA, Usir E, Azman NH, Ismail H, Fahrni ML, Rafar NRA, Neoh CF, Othman MF, Bahrin NZZ, Zaid WSW, Zamri F, Andayani N, Ariani F, Sarnianto P, Sofia Z, Naimat F, Fahrni ML, Min BH, Yaacob NLC, Ngadimon IW, Fahrni ML, Rahman S, Zunaidi NNH, Suhaimi AM, Manan MM, Jamaluddin NL, Manan MM, Nadiah Loke AL, Khan MAN, Saroge NAB, Khan MAN, Ng WS, Wong PC, Said SNM. Abstracts from the 1st JoPPP Conference on Pharmaceutical Policy and Practice. J Pharm Policy Pract 2020. [PMCID: PMC6988188 DOI: 10.1186/s40545-019-0201-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
|
2
|
Ismail WI, Ahmad Hassali MA, Farooqui M, Saleem F, Roslan MNF. Complementary and alternative medicine (CAM) disclosure to health care providers: A qualitative insight from Malaysian thalassemia patients. Complement Ther Clin Pract 2018; 33:71-76. [PMID: 30396630 DOI: 10.1016/j.ctcp.2018.06.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 05/21/2018] [Accepted: 06/05/2018] [Indexed: 11/17/2022]
Abstract
BACKGROUND AND PURPOSE This study investigated the disclosure of complementary and alternative medicine (CAM) use to health care providers by Malaysian thalassemia patients. METHODS The semi-structured interviews were audio taped, transcribed verbatim, and translated into English. RESULTS Thematic analysis identified four themes: 1) reason for CAM disclosure, 2) attempt to disclose CAM, 3) withdrawal from CAM disclosure, and 4) non-disclosure of CAM use. The reason for patients' disclosure of CAM use to healthcare providers is because they wanted to find information about CAM and were afraid of the interaction between the conventional medicine and CAM. Patients also disclosed the use of CAM because they were not satisfied with the conventional medicine that had caused them harm. CONCLUSION Effective communication between patients and health care providers is important, especially for patients who are undergoing conventional thalassemia treatment, for fear that there is an interaction between conventional treatment and CAM use.
Collapse
Affiliation(s)
- Wan Ismahanisa Ismail
- Faculty of Health Sciences Universiti Teknologi MARA, Penang, Kepala Batas, 13200, Penang, Malaysia; Discipline of Social & Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
| | - Mohamed Azmi Ahmad Hassali
- Discipline of Social & Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
| | - Maryam Farooqui
- Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Qassim, Saudi Arabia
| | - Fahad Saleem
- Faculty of Pharmacy and Health Sciences, University of Balochistan, Pakistan
| | | |
Collapse
|